Stay updated on SBRT-Immunotherapy in Early Lung Cancer: Clinical Trial
Sign up to get notified when there's something new on the SBRT-Immunotherapy in Early Lung Cancer: Clinical Trial page.

Latest updates to the SBRT-Immunotherapy in Early Lung Cancer: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2. Removed Notice about lapse in government funding and the older Revision: v3.4.1.SummaryDifference0.4%

- Check21 days agoChange DetectedThe page now displays a government funding and operating status notice and the revision changed from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedShow glossary has been added, and the page now displays 'Last Update Submitted that Met QC Criteria' along with Revision: v3.4.0. The items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' have been removed.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter now shows Revision: v3.3.3. The HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision: v3.3.2 is now displayed, replacing the previous v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to SBRT-Immunotherapy in Early Lung Cancer: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT-Immunotherapy in Early Lung Cancer: Clinical Trial page.